Hsa_circ_0007312 Promotes Third-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance through Pyroptosis and Apoptosis via the MiR-764/MAPK1 Axis in Lung Adenocarcinoma Cells

Purposes: Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) used for patients with gefitinib (first-generation EGFR-TKI) resistance, but osimertinib resistance inevitably occurs. Therefore, it is necessary to explore the mechanisms of osimertinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Chenyue, Ma, Zeming, Si, Jiahui, An, Guo, Zhang, Wenlong, Li, Shaolei, Ma, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254875/
https://www.ncbi.nlm.nih.gov/pubmed/35812182
http://dx.doi.org/10.7150/jca.72066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254875/
https://www.ncbi.nlm.nih.gov/pubmed/35812182
http://dx.doi.org/10.7150/jca.72066

Ejemplares similares